Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction

Diabetes and Vascular Disease Research

Volumn 12, Issue 4, 2015, Pages 234-238

  Lam, Carolyn S P ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Diabetic cardiomyopathy; diastolic dysfunction; ejection fraction; heart failure

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULAR CELL ADHESION MOLECULE 1; XANTHINE OXIDASE;

ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; ENDOTHELIAL DYSFUNCTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MORBIDITY; NONHUMAN; OXIDATIVE STRESS; PANDEMIC; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN PHOSPHORYLATION; SYMPTOMATOLOGY; COMPLICATION; HEART FAILURE; HEART FAILURE, DIASTOLIC; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; RISK ASSESSMENT; RISK FACTOR;

ASYMPTOMATIC DISEASES; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; HEART FAILURE; HEART FAILURE, DIASTOLIC; HUMANS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84936991885     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164115579006     Document Type: Article

References (29)

1. Hunt SA, Baker DW, Chin MH,. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: executive summary-a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104: 2996-3007.
2. Oktay AA, Rich JD, Shah SJ,. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep 2013; 10: 401-410.
3. Wild S, Roglic G, Green A,. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
4. Bertoni AG, Hundley WG, Massing MW,. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004; 27: 699-703.
5. Lam CS, Donal E, Kraigher-Krainer E,. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 2011; 13: 18-28.
6. Klapholz M, Maurer M, Lowe AM,. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004; 43: 1432-1438.
7. Paulus WJ, Tschope C,. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013; 62: 263-271.
8. Tschope C, Lam CS,. Diastolic heart failure: what we still don't know. Looking for new concepts, diagnostic approaches, and the role of comorbidities. Herz 2012; 37: 875-879.
9. Jay D, Hitomi H, Griendling KK,. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2006; 40: 183-192.
10. Hare JM, Stamler JS,. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 2005; 115: 509-517.
11. Hartge MM, Unger T, Kintscher U,. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 2007; 4: 84-88.
12. Pacher P, Szabo C,. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 2006; 6: 136-141.
13. Forstermann U, Munzel T,. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708-1714.
14. Borlaug BA, Olson TP, Lam CS,. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010; 56: 845-854.
15. Akiyama E, Sugiyama S, Matsuzawa Y,. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2012; 60: 1778-1786.
16. Lok DJ, Klip IT, Voors AA,. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail 2014; 16: 958-966.
17. Lam CS, Brutsaert DL,. Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction. J Am Coll Cardiol 2012; 60: 1787-1789.
18. Van Heerebeek L, Hamdani N, Falcão-Pires I,. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 2012; 126: 830-839.
19. Takimoto E, Champion HC, Li M,. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 2005; 11: 214-222.
20. Komajda M, Lam CS,. Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J 2014; 35: 1022-1032.
21. Van Heerebeek L, Hamdani N, Handoko ML,. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008; 117: 43-51.
22. Ernande L, Derumeaux G,. Diabetic cardiomyopathy: myth or reality? Arch Cardiovasc Dis 2012; 105: 218-225.
23. Van Heerebeek L, Borbély A, Niessen HW,. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113: 1966-1973.
24. Linke WA,. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 2008; 77: 637-648.
25. Hamdani N, Bishu KG, von Frieling-Salewsky M,. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res 2013; 97: 464-471.
26. Lam CS, Lyass A, Kraigher-Krainer E,. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 2011; 124: 24-30.
27. From AM, Scott CG, Chen HH,. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study. J Am Coll Cardiol 2010; 55: 300-305.
28. Lindman BR, Dávila-Román VG, Mann DL,. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study. J Am Coll Cardiol 2014; 64: 541-549.
29. Stahrenberg R, Edelmann F, Mende M,. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 2010; 53: 1331-1340.